CIK: 0001012622 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 14, 2025
Total Value ($000): $183,665 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| WGS | GENEDX HOLDINGS CORP | 1,023,468 | $78,664 | 42.8% | $6.26 | +1016.7% | COM CL A | 81663L200 |
| BHVN | BIOHAVEN LTD | 851,770 | $31,814 | 17.3% | $22.35 | +108.8% | COM | G1110E107 |
| — | SELECT SECTOR SPDR TR | 115,000 | $15,821 | 8.6% | — | — | Put | 81369Y959 |
| ARDX | ARDELYX INC | 2,089,431 | $10,593 | 5.8% | $5.74 | -3.8% | COM | 039697107 |
| — | SPRINGWORKS THERAPEUTICS INC | 254,773 | $9,205 | 5.0% | $37.25 | — | COM | 85205L107 |
| — | BIOHAVEN LTD | 200,000 | $7,470 | 4.1% | — | — | Call | G1110E907 |
| QDEL | QUIDELORTHO CORP | 118,291 | $5,270 | 2.9% | $99.04 | -58.7% | COM | 219798105 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 535,558 | $4,027 | 2.2% | $4.97 | +52.6% | COM | 09058V103 |
| — | NOVAVAX INC | 466,000 | $3,747 | 2.0% | — | — | Call | 670002901 |
| — | ARDELYX INC | 584,700 | $2,964 | 1.6% | — | — | Call | 039697907 |
| FORA | FORIAN INC | 1,366,107 | $2,814 | 1.5% | $10.60 | -80.4% | COM | 34630N106 |
| — | TELADOC HEALTH INC | 297,700 | $2,706 | 1.5% | — | — | Call | 87918A905 |
| PLTR | PALANTIR TECHNOLOGIES INC | 28,500 | $2,155 | 1.2% | $31.66 | +84.0% | CL A | 69608A108 |
| CAVA | CAVA GROUP INC | 18,600 | $2,098 | 1.1% | $54.87 | +143.0% | COM | 148929102 |
| — | SPRINGWORKS THERAPEUTICS INC | 55,800 | $2,016 | 1.1% | — | — | Call | 85205L907 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 145,064 | $1,178 | 0.6% | $12.87 | -3.8% | COM | 71722W107 |
| PACB | PACIFIC BIOSCIENCES CALIF IN | 279,638 | $512 | 0.3% | $4.70 | -58.5% | COM | 69404D108 |
| BIIB | BIOGEN INC | 2,412 | $369 | 0.2% | $213.68 | -21.1% | COM | 09062X103 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 32,500 | $242 | 0.1% | $12.95 | -28.1% | COM NEW | 30233G209 |